Quantbot Technologies’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,600
Closed -$123K 2034
2023
Q1
$123K Buy
+13,600
New +$119K 0.01% 1034
2022
Q3
Sell
-10,300
Closed -$54K 2176
2022
Q2
$54K Buy
10,300
+3,818
+59% +$23.1K 0.01% 1292
2022
Q1
$42K Buy
+6,482
New +$57.8K ﹤0.01% 1237
2021
Q2
Sell
-4,028
Closed -$127K 1936
2021
Q1
$127K Buy
+4,028
New +$164K 0.01% 829
2020
Q4
Sell
-800
Closed -$37K 1744
2020
Q3
$37K Buy
+800
New +$27.5K ﹤0.01% 909
2019
Q4
Sell
-800
Closed -$19K 1646
2019
Q3
$19K Buy
+800
New +$20K ﹤0.01% 1117

Other funds holding ZYME

Quantbot Technologies's ZYME Position: Q2 2023 in Review

Quantbot Technologies sold out of Zymeworks (ZYME) in Q2 2023, closing a stake of 13,600 shares — an estimated $123K sold.

Quantbot Technologies first reported a position in ZYME in Q3 2019 and held it in 6 quarters. The position peaked at $127K in Q1 2021. 137 funds tracked by Wall St. Rank hold ZYME as of Q2 2023.

  • Quantbot Technologies reported no remaining Zymeworks position as of Q2 2023 after selling out during the quarter.
  • Quantbot Technologies sold 13,600 Zymeworks shares in Q2 2023, an estimated $123K.
  • Quantbot Technologies first reported a position in Zymeworks in Q3 2019 and held it in 6 quarters.
  • Quantbot Technologies's Zymeworks position peaked at $127K in Q1 2021.
  • 137 funds tracked by Wall St. Rank held Zymeworks as of Q2 2023.

Based on Quantbot Technologies's 13F filing for Q2 2023, filed 8 Aug 2023.